Infectious disease research is evolving faster than ever, driven by the need for more sensitive, scalable, and precise molecular tools. As pharma and biotech organizations push to accelerate vaccine development, improve early‑stage decision‑making, and enhance clinical trial success rates, the ability to extract more insight from limited biological samples has become essential.
Today’s clinical trial laboratories, especially those supporting virology, vaccine development, and early‑phase drug discovery, require technologies that deliver high‑resolution data with minimal sample usage. This is where the next generation of digital PCR (ddPCR) platforms is transforming the landscape.
Clinical studies typically produce a limited number of high‑value samples, particularly in early‑phase infectious disease and vaccine research. Laboratories must maximise data output, detect low‑frequency mutations, support precise quantification, and maintain accuracy across high‑throughput clinical trial settings.
The Bio‑Rad QX700S ddPCR platform delivers a powerful leap forward in molecular diagnostics, infectious disease research, and pharma‑grade assay development. It offers high sensitivity, 7‑color multiplexing enabling up to 21 targets, ultra‑low sample volume requirements, and high‑throughput automation.
ddPCR strengthens its role as a core component of modern molecular biology strategies in drug development. When paired with Next Generation Sequencing (NGS), digital PCR enhances detection sensitivity and supports comprehensive analytical frameworks for infectious disease studies, vaccine efficacy monitoring, viral mutation analysis, and gene therapy characterization.
Key Benefits:
• More insights from every sample
• Unmatched sensitivity for mutation verification
• Rapid turnaround times
• Reproducible, high‑quality data
• Future‑ready molecular workflows
Empowering Next‑Gen Infectious Disease & Vaccine Development
hVIVO becomes the first global clinical trial laboratory to adopt the Bio-Rad QX700S platform, reinforcing our commitment to infectious and immunology disease research and clinical trials.
Learn more about our laboratory services.